Last reviewed · How we verify

NCT06988982

Lipid Emulsion for Reversal of Spinal Anesthesia in Ambulatory Surgery

Recruiting now NA Last updated 25 May 2025
What this trial tests

NA trial testing Intravenous Lipid Emulsion 20% in Spinal Anaesthesia in 42 participants. Currently enrolling.

Timeline
1 June 2025
Primary endpoint
30 December 2025
1 January 2026

Quick facts

Lead sponsorZagazig University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeother
Enrollment42
Start date1 June 2025
Primary completion30 December 2025
Estimated completion1 January 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Zagazig University

Who can join

Adults 21 to 70, any sex, with Spinal Anaesthesia or Spinal Anesthesia Evaluation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ambulatory surgery places high demands on anesthetic technique. rapid onset and offset of anesthesia, rapid recovery of protective reflexes, mobility and micturition, are required. Since the inception of ambulatory surgery, the favored anesthetic technique has been general anesthesia with short-acting drugs. Concerns about the time to perform spinal anesthesia and the risks of prolonged motor block and urinary retention have limited its use. Alpha-blockers, lavage fluids for epidural space, insulin, and intravenous lipid emulsions, are still being discussed to shorten and reverse adverse effect of different LAs used for spinal anaesthesia, hence we will evaluate the effectiveness of intravenous lipid emulsion for reversing the neural blockade of spinal anaesthesia in patients undergoing ambulatory surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Spinal Anaesthesia

Currently open trials in the same condition.

Other Zagazig University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06988982.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing